BIOQUELL Worldwide
IN THE NEWS
Directors' Dealings - Purchase of Shares
Appointment of Sir Ian Carruthers OBE as a Non-Executive Director Bioquell PLC – 2010 interim results Results of Bioquell PLC AGM Interim Management Statement Annual Report 2009 Press Release Notice of Annual General Meeting 2010 and form of Proxy BIOQUELL delivers strong growth in revenues and profit in 2009 Interim Management Statement Notification of major interest BIOQUELL PLC - Sale of Shares Award by the NHS Purchasing and Supply Agency to BIOQUELL BIOQUELL PLC - 2009 interim results DoH & PASA Publish report on Success of BIOQUELL System in Showcase Hospital Programme Results of AGM Proxy Voting May 2009 AGM Results Notice Results of AGM Proxy voting Notice of Annual General Meeting Interim Management Statement Directors’ exercise of options and acquisition of Shares Grant of options to Directors Annual Report 2008 BIOQUELL delivers strong growth in pre-tax profit and cash in 2008 BIOQUELL takes top prize at the Department of Health HCAI Technology Innovation Summit 2008 Interim Results Purchase of ordinary shares Directors’ dealings – purchase of Shares Results of AGM Proxy voting, Results of EGM Proxy voting, Results of Separate Class Meeting Proxy voting BIOQUELL PLC EGM - Cancellation of Share Premium Account Adoption of New Articles of Association & Amendment of the BIOQUELL Share Option Schemes PLC PRESS RELEASE: 2007 Preliminary Results PRESS RELEASE: Award of Joint Material Decontamination System Sub-Contract |
News release
BIOQUELL has won a prestigious award from the Department of Health and NHS Purchasing and Supply Agency (PASA) in recognition of its Hydrogen Peroxide Vapour (HPV) decontamination technology, offering the greatest contribution in controlling Clostridium difficile. The awards have been created to highlight and celebrate innovation and success within the field of HCAI related technology and technological developments. They recognise that new and innovative technologies are helping to save lives and are making it easier for doctors and nurses to fight infection. The Department of Health and PASA launched the awards programme to highlight and celebrate innovation and success within the field of HCAI related technology and technological developments. Matt Parks, Head of BIOQUELL's UK healthcare decontamination practice, said on receiving the award; "We are thrilled to have won such a prestigious award following many years of hard work carrying out painstaking "superbug" eradication research in hospitals around the world. Winning this award highlights the importance of BIOQUELL’s presence within the NHS to help combat the threat posed by Hospital Acquired Infection”. Extract from the PASA news release:
To view the full PASA news release as a PDF, Click here... 
|
.jpg)
BIOQUELL’s fully managed RBDS decontamination service was recently showcased in the HCAI technology innovation showcase programme as one of only six technologies trialled throughout seven UK hospitals. The trials proved that such a service can easily be implemented as part of a hospitals infection control regime offering quick turn around times in the decontamination of infected areas.